7700 E Arapahoe Rd., Centennial, 80112-1268, CO, USA medicalresearch@onlinescientificresearch.info


International Scientific Indexing (ISI) Indexed Journal Applied Medical Research ISSN: 2149 - 2018
Applied Medical Research. 2024; 11(2):(153-154)
doi: -


Oncology Breakthroughs to A New Pace of Precision Diagnostics and Therapeutics

Hung-Chih Lai, Wen-Hung Kuo and Chen Yeh*

Abstract
Background: When it comes to developing new cancer diagnostics (Dx) and therapeutics (Rx), time is of the essence-for the patients that need treatments most, every day counts. Traditional benchmarks of Dx and Rx have delivered favorable clinical outcomes on a slower timeline than patients can afford.


Methods: Transformative Dx tools such as liquid biopsy in combination with next-generation sequencing (NGS) have emerged as a standard of care to inform clinical decision, treatment response and prognosis much sooner.

Results: As the cutting-edge Dx technology continues to advance, it will complement Rx innovation like antibody-drug conjugates (ADCs), chimeric antigen receptor T-cell (CAR-T) therapy and messenger RNA (mRNA) medicine, and help lifesaving treatments reach patients earlier than ever.

Conclusions: Highly personalized Dx and Rx breakthroughs can empower providers and researchers alike with precise and real-world data on each patients’ cancer, helping them to develop and deliver real-time precision oncology care.